These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
483 related articles for article (PubMed ID: 874091)
1. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen. Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091 [TBL] [Abstract][Full Text] [Related]
2. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. Meier HL; Pierce JV; Colman RW; Kaplan AP J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082 [TBL] [Abstract][Full Text] [Related]
3. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation. Kaplan AP Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144 [TBL] [Abstract][Full Text] [Related]
4. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen. Revak SD; Cochrane CG; Griffin JH J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009 [TBL] [Abstract][Full Text] [Related]
5. Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogen. Colman RW; Scott CF; Shames PV; Dayal V; Liu CY; Kirby EP Trans Assoc Am Physicians; 1979; 92():208-17. PubMed ID: 317690 [TBL] [Abstract][Full Text] [Related]
6. Purification of high molecular weight kininogen and the role of this agent in blood coagulation. Saito H J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664 [TBL] [Abstract][Full Text] [Related]
7. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis. Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795 [TBL] [Abstract][Full Text] [Related]
8. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor. Scott CF; Silver LD; Schapira M; Colman RW J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202 [TBL] [Abstract][Full Text] [Related]
9. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089 [TBL] [Abstract][Full Text] [Related]
10. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents. EspaƱa F; Ratnoff OD J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770 [TBL] [Abstract][Full Text] [Related]
11. Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen. Matheson RT; Miller DR; Lacombe MJ; Han YN; Iwanaga S; Kato H; wuepper KD J Clin Invest; 1976 Dec; 58(6):1395-406. PubMed ID: 993350 [TBL] [Abstract][Full Text] [Related]
12. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation. Saito H; Ratnoff OD Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254 [TBL] [Abstract][Full Text] [Related]
13. Role of HMW kininogen in surface-mediated activation of Factor XII. Shimada T; Sugo T; Kato H; Iwanaga S Adv Exp Med Biol; 1983; 156():73-85. PubMed ID: 6134440 [TBL] [Abstract][Full Text] [Related]
14. The relative amidolytic activity of Hageman factor (factor XII) and its fragments. The effect of high-molecular-weight kininogen and kaolin. Ratnoff OD J Lab Clin Med; 1980 Aug; 96(2):267-77. PubMed ID: 7400662 [TBL] [Abstract][Full Text] [Related]
15. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein. Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861 [TBL] [Abstract][Full Text] [Related]
16. Structural and functional characterization of factor XII. Tans G; Rosing J Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074 [TBL] [Abstract][Full Text] [Related]
17. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain. Thompson RE; Mandle R; Kaplan AP Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905 [TBL] [Abstract][Full Text] [Related]
18. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein. Wiggins RC; Bouma BN; Cochrane CG; Griffin JH Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705 [TBL] [Abstract][Full Text] [Related]
19. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI. Kaplan AP Prog Hemost Thromb; 1978; 4():127-75. PubMed ID: 362477 [No Abstract] [Full Text] [Related]
20. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor. Griffin JH; Cochrane CG Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]